The Global Digital Therapeutics (DTx) Market size is set to grow by USD 13.1 billion by 2026 according to MarketsandMarkets. Growth in this market is primarily driven by the rising focus on preventive healthcare, significant increase in venture capital investments and benefits of digital therapeutics.

 

Technological advancements in lab freezers also drive the growth of this market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. The global Digital Therapeutics (DTx) market is fragmented, and the degree of fragmentation will accelerate during the forecast period. 

Request Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724

Digital Therapeutics (DTx) Market Segmentation

 

Digital Therapeutics Market, by Application

·         Preventive Applications

·         Treatment/Care-related Applications

Geography

o    North America

o    Europe

o    Asia

o    ROW

Global Digital Therapeutics (DTx) Market Vendor Analysis

To help businesses improve their market position, MnM report provides a detailed analysis of around 25 vendors operating in the market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724

Some of the major vendors of the global Digital Therapeutics (DTx) market in the health care industry include:

Omada Health (US), WellDoc (US), Pear Therapeutics (US), Better Therapeutics (US), Happify (US), Proteus Digital Health (US), Propeller Health (US), Noom (US), Livongo Health (US), Akili Interactive Labs (US), Kaia Health (Germany), Mango Health (US), Click Therapeutics (US), Canary Health (US), CogniFit (US), Ayogo Health (Canada), Mindstrong Health (US), 2Morrow (US), Wellthy Therapeutics (India), Cognoa (US), and Ginger (US)

Regional Analysis

The market in North America is expected to grow at the highest CAGR. Factors such as the influx of new startups, increasing investments in digital therapeutics, improvements in the reimbursement structure for digital therapeutics, and government initiatives to support technological advancements drive market growth in this region. North America also held the largest share of the market, followed by Europe.

Global Digital Therapeutics (DTx) Market Key Highlights

·         CAGR of the market during the forecast period

·         Detailed information on factors that will assist global Digital Therapeutics (DTx) market growth during the next five years

·         Estimation of the global Digital Therapeutics (DTx) market size and its contribution to the parent market

·         Predictions on upcoming trends and changes in consumer behavior

·         The growth of the global Digital Therapeutics (DTx) market

·         Analysis of the market’s competitive landscape and detailed information on vendors

·         Comprehensive details of factors that will challenge the growth of global Digital Therapeutics (DTx) market vendors

Key Developments in Global Digital Therapeutics (DTx) Market

·         In April 2021, Welldoc(US) partnered with Dexacom (US). This partnership helped provide BlueStar with Dexcom G6 CGM as a single platform to people with Type 2 diabetes for improved health.

·         In March 2021, Pear Therapeutics (US) partnered with Sprectrum Health Systems (US). Tufts Health Plan and Spectrum Health Systems announced a collaboration with Pear Therapeutics to test FDA-approved digital therapeutics to help people with substance use disorders and improve their recovery journeys by delivering solutions for improved treatment access and care innovation journeys by delivering solutions for improved treatment access and care innovation

·         In January 2020, Crossroads Treatment Centers (US) collaborated with Pear Therapeutics (US) to implement the company’s digital platform reSET-O to help patients with opioid abuse and addiction.

Each of these players has been profiled in the global Digital Therapeutics (DTx) market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

To speak to our analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=51646724